Alan Y Hsu

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 12

Top Topics

Vascular Endothelial Growth Factor

Optical Coherence Tomography

Risk Assessment

Age Related Macular Degeneration

Top Venues

Medicina (Kaunas, Lithuania)

Journal of clinical medicine

Journal of medical virology

This page only lists publications with an associated author ORCID identifier.

Publications

Alan Y Hsu, Yu-Hsun Wang, Chun-Ju Lin, You-Ling Li, Ning-Yi Hsia, Chun-Ting Lai, Hou-Ting Kuo, Huan-Sheng Chen, Yi-Yu Tsai, James Cheng-Chung Wei
Assessing Uveitis Risk following Pediatric Down Syndrome Diagnosis: A TriNetX Database Study. Medicina (Kaunas, Lithuania) 60 (5) (2024)
Bing-Qi Wu, Hou-Ting Kuo, Alan Y Hsu, Chun-Ju Lin, Chun-Ting Lai, Yi-Yu Tsai
The Clinical Efficacy of Different Relaxation Exercises on Intraocular Pressure Reduction: A Meta-Analysis. Journal of clinical medicine 13 (9) (2024)
Alan Y Hsu, Yu-Hsun Wang, Chun-Ju Lin, You-Ling Li, Ning-Yi Hsia, Chun-Ting Lai, Hou-Ting Kuo, Huan-Sheng Chen, Yi-Yu Tsai, James Cheng-Chung Wei
Assessing Uveitis Risk following Pediatric Down Syndrome Diagnosis: A TriNetX Database Study. Medicina (Kaunas, Lithuania) 60 (5) (2024)
Bing-Qi Wu, Hou-Ting Kuo, Alan Y Hsu, Chun-Ju Lin, Chun-Ting Lai, Yi-Yu Tsai
The Clinical Efficacy of Different Relaxation Exercises on Intraocular Pressure Reduction: A Meta-Analysis. Journal of clinical medicine 13 (9) (2024)
Alan Y Hsu, Yu-Hsun Wang, Chun-Ju Lin, You-Ling Li, Ning-Yi Hsia, Chun-Ting Lai, Hou-Ting Kuo, Huan-Sheng Chen, Yi-Yu Tsai, James Cheng-Chung Wei
Assessing Uveitis Risk following Pediatric Down Syndrome Diagnosis: A TriNetX Database Study. Medicina (Kaunas, Lithuania) 60 (5) (2024)
Alan Y Hsu, Chun-Ju Lin, Ning-Yi Hsia, Yu-Hsun Wang, Jing-Xing Li, Huan-Sheng Chen, James Cheng-Chung Wei, Yi-Yu Tsai
Reply to comment on "The risk assessment of uveitis after COVID-19 diagnosis by Wu et al. 2024". Journal of medical virology 96 (5) (2024)
Alan Y Hsu, Chih-Ying Lin, Chun-Ju Lin, Chun-Ting Lai, Ning-Yi Hsia, Jane-Ming Lin, Peng-Tai Tien, Ping-Ping Meng, Wei-Ning Ku, Wen-Lu Chen, Yi-Yu Tsai
Short-Term Effects of Brolucizumab in the Treatment of Wet Age-Related Macular Degeneration or Polypoidal Choroidopathy Refractory to Previous Anti-Vascular Endothelial Growth Factor Therapy. Medicina (Kaunas, Lithuania) 58 (12) (2022)
Alan Y Hsu, Chih-Ying Lin, Chun-Ju Lin, Chun-Ting Lai, Ning-Yi Hsia, Jane-Ming Lin, Peng-Tai Tien, Ping-Ping Meng, Wei-Ning Ku, Wen-Lu Chen, Yi-Yu Tsai
Short-Term Effects of Brolucizumab in the Treatment of Wet Age-Related Macular Degeneration or Polypoidal Choroidopathy Refractory to Previous Anti-Vascular Endothelial Growth Factor Therapy. Medicina (Kaunas, Lithuania) 58 (12) (2022)
Alan Y Hsu, Chih-Ying Lin, Chun-Ju Lin, Chun-Ting Lai, Ning-Yi Hsia, Jane-Ming Lin, Peng-Tai Tien, Ping-Ping Meng, Wei-Ning Ku, Wen-Lu Chen, Yi-Yu Tsai
Short-Term Effects of Brolucizumab in the Treatment of Wet Age-Related Macular Degeneration or Polypoidal Choroidopathy Refractory to Previous Anti-Vascular Endothelial Growth Factor Therapy. Medicina (Kaunas, Lithuania) 58 (12) (2022)
Alan Y Hsu, Chih-Ying Lin, Chun-Ju Lin, Chun-Ting Lai, Ning-Yi Hsia, Jane-Ming Lin, Peng-Tai Tien, Ping-Ping Meng, Wei-Ning Ku, Wen-Lu Chen, Yi-Yu Tsai
Short-Term Effects of Brolucizumab in the Treatment of Wet Age-Related Macular Degeneration or Polypoidal Choroidopathy Refractory to Previous Anti-Vascular Endothelial Growth Factor Therapy. Medicina (Kaunas, Lithuania) 58 (12) (2022)
Alan Y Hsu, Chih-Ying Lin, Chun-Ju Lin, Chun-Ting Lai, Ning-Yi Hsia, Jane-Ming Lin, Peng-Tai Tien, Ping-Ping Meng, Wei-Ning Ku, Wen-Lu Chen, Yi-Yu Tsai
Short-Term Effects of Brolucizumab in the Treatment of Wet Age-Related Macular Degeneration or Polypoidal Choroidopathy Refractory to Previous Anti-Vascular Endothelial Growth Factor Therapy. Medicina (Kaunas, Lithuania) 58 (12) (2022)
Alan Y Hsu, Chih-Ying Lin, Chun-Ju Lin, Chun-Ting Lai, Ning-Yi Hsia, Jane-Ming Lin, Peng-Tai Tien, Ping-Ping Meng, Wei-Ning Ku, Wen-Lu Chen, Yi-Yu Tsai
Short-Term Effects of Brolucizumab in the Treatment of Wet Age-Related Macular Degeneration or Polypoidal Choroidopathy Refractory to Previous Anti-Vascular Endothelial Growth Factor Therapy. Medicina (Kaunas, Lithuania) 58 (12) (2022)